norfloxacin has been researched along with Prostatitis in 16 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Prostatitis: Infiltration of inflammatory cells into the parenchyma of PROSTATE. The subtypes are classified by their varied laboratory analysis, clinical presentation and response to treatment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We treated 15 men who had chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/or carbenicillin with 400 mg." | 7.68 | The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/or carbenicillin. ( Darras, FS; Schaeffer, AJ, 1990) |
| "The clinical efficacy of norfloxacin (NFLX) was evaluated in 74 patients having chronic prostatitis with the subjective symptoms suggesting the inflammations of prostate and more than five white bloodcells (WBCs)/hpf in their prostatic secretions (EPS)." | 7.67 | [The therapeutic effect of norfloxacin on chronic prostatitis]. ( Gouro, T; Henmi, I; Igawa, K; Kadono, M; Kumamoto, Y; Maekwa, S; Oguma, K; Okayama, S; Sakai, S; Tsukamoto, T, 1987) |
| " Norfloxacin, a new quinolone antibacterial agent particularly active in urinary tract infections, gave excellent results (400 mg every 12 h for 10 days) in the treatment of chronic-relapsing prostatitis in a group of 20 patients." | 7.67 | Norfloxacin in prostatitis: correlation between HPLC tissue concentrations and clinical results. ( Bologna, M; Carlucci, G; Flammini, D; Forchetti, CM; Vaggi, L, 1985) |
| "Norfloxacin is a lipid-soluble weak organic acid bound to plasma proteins to a low extent." | 6.66 | Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men. ( Cook, T; Hoagland, VL; Sabbaj, J, 1986) |
| "We treated 15 men who had chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/or carbenicillin with 400 mg." | 3.68 | The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/or carbenicillin. ( Darras, FS; Schaeffer, AJ, 1990) |
| "The clinical efficacy of norfloxacin (NFLX) was evaluated in 74 patients having chronic prostatitis with the subjective symptoms suggesting the inflammations of prostate and more than five white bloodcells (WBCs)/hpf in their prostatic secretions (EPS)." | 3.67 | [The therapeutic effect of norfloxacin on chronic prostatitis]. ( Gouro, T; Henmi, I; Igawa, K; Kadono, M; Kumamoto, Y; Maekwa, S; Oguma, K; Okayama, S; Sakai, S; Tsukamoto, T, 1987) |
| " Norfloxacin, a new quinolone antibacterial agent particularly active in urinary tract infections, gave excellent results (400 mg every 12 h for 10 days) in the treatment of chronic-relapsing prostatitis in a group of 20 patients." | 3.67 | Norfloxacin in prostatitis: correlation between HPLC tissue concentrations and clinical results. ( Bologna, M; Carlucci, G; Flammini, D; Forchetti, CM; Vaggi, L, 1985) |
| "Norfloxacin is a lipid-soluble weak organic acid bound to plasma proteins to a low extent." | 2.66 | Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men. ( Cook, T; Hoagland, VL; Sabbaj, J, 1986) |
| " We employed a rat model of chronic bacterial prostatitis to investigate any pharmacokinetic differences that may exist between uninflamed and inflamed prostate glands." | 1.29 | Antibiotic pharmacokinetics in the inflamed prostate. ( Ceri, H; Clark, J; Downey, J; Nickel, JC; Olson, M, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (75.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glick, R | 1 |
| Epstein, DS | 1 |
| Aponso, DT | 1 |
| Peppas, T | 1 |
| Petrikkos, G | 1 |
| Deliganni, V | 1 |
| Zoumboulis, P | 1 |
| Koulentianos, E | 1 |
| Giamarellou, H | 1 |
| Bologna, M | 2 |
| Vaggi, L | 2 |
| Forchetti, CM | 2 |
| Martini, E | 1 |
| Jensen, KM | 1 |
| Madsen, PO | 1 |
| Nickel, JC | 1 |
| Downey, J | 1 |
| Clark, J | 1 |
| Ceri, H | 1 |
| Olson, M | 1 |
| Schaeffer, AJ | 1 |
| Darras, FS | 1 |
| Morikawa, M | 1 |
| Tokunaka, S | 1 |
| Yachiku, S | 1 |
| Yamauchi, K | 1 |
| Wakabayashi, A | 1 |
| Inagaki, N | 1 |
| Nishihara, M | 1 |
| Yamaguchi, S | 1 |
| Boerema, JB | 1 |
| Bischoff, W | 1 |
| Borsa, F | 1 |
| Humbert, G | 1 |
| Sheikh, MA | 1 |
| Naqvi, SA | 1 |
| Sabbaj, J | 1 |
| Hoagland, VL | 1 |
| Cook, T | 1 |
| Dan, M | 1 |
| Golomb, J | 1 |
| Gorea, A | 1 |
| Lindner, A | 1 |
| Berger, SA | 1 |
| Kumamoto, Y | 1 |
| Tsukamoto, T | 1 |
| Sakai, S | 1 |
| Gouro, T | 1 |
| Maekwa, S | 1 |
| Oguma, K | 1 |
| Henmi, I | 1 |
| Igawa, K | 1 |
| Kadono, M | 1 |
| Okayama, S | 1 |
| Denis, B | 1 |
| Wauters, G | 1 |
| Wese, F | 1 |
| Van Cangh, PJ | 1 |
| Flammini, D | 1 |
| Carlucci, G | 1 |
1 trial available for norfloxacin and Prostatitis
| Article | Year |
|---|---|
Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men.
Topics: Anti-Infective Agents, Urinary; Bacteria; Drug Combinations; Humans; Male; Microbial Sensitivity Tes | 1986 |
15 other studies available for norfloxacin and Prostatitis
| Article | Year |
|---|---|
Spontaneous bilateral quadriceps tendon rupture associated with norfloxacin.
Topics: Accidental Falls; Aged; Anti-Bacterial Agents; Humans; Knee Injuries; Male; Norfloxacin; Prostatitis | 2015 |
Efficacy of long-term therapy with norfloxacin in chronic bacterial prostatitis.
Topics: Acute Disease; Adult; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Humans; Male; Mi | 1989 |
Bactericidal intraprostatic concentrations of norfloxacin.
Topics: Anti-Infective Agents; Humans; Male; Nalidixic Acid; Norfloxacin; Prostate; Prostatitis | 1983 |
Distribution of quinoline carboxylic acid derivatives in the dog prostate.
Topics: 4-Quinolones; Administration, Oral; Animals; Anti-Infective Agents; Dogs; Drug Evaluation, Preclinic | 1983 |
Antibiotic pharmacokinetics in the inflamed prostate.
Topics: Animals; Bacterial Infections; Chronic Disease; Male; Norfloxacin; Prostatitis; Rats; Rats, Sprague- | 1995 |
The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/or carbenicillin.
Topics: Carbenicillin; Chronic Disease; Escherichia coli Infections; Follow-Up Studies; Humans; Male; Middle | 1990 |
[The therapeutic effect of norfloxacin on chronic prostatitis].
Topics: Adult; Aged; Bacterial Infections; Chronic Disease; Drug Evaluation; Humans; Leukocyte Count; Male; | 1990 |
New 4-quinolones in the treatment of urinary tract infections.
Topics: Anti-Infective Agents, Urinary; Ciprofloxacin; Drug Combinations; Humans; Male; Norfloxacin; Pefloxa | 1986 |
[Norfloxacin treatment of acute cystitis in the female and bacterial prostatitis].
Topics: Adult; Anti-Infective Agents, Urinary; Bacterial Infections; Cystitis; Female; Humans; Male; Microbi | 1985 |
[Treatment of urinary tract infections].
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Chlamydia Infections; Female; Humans; Lactams | 1985 |
A study of the use of norfloxacin in prostatitis.
Topics: Adult; Escherichia coli Infections; Humans; Male; Norfloxacin; Prostatitis; Staphylococcal Infection | 1987 |
Penetration of norfloxacin into human prostatic tissue following single-dose oral administration.
Topics: Aged; Aged, 80 and over; Humans; Male; Middle Aged; Norfloxacin; Prostate; Prostatitis | 1987 |
[The therapeutic effect of norfloxacin on chronic prostatitis].
Topics: Adult; Aged; Chronic Disease; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Male; Micr | 1987 |
Intraprostatic bactericidal concentrations of Norfloxacin.
Topics: Administration, Oral; Aged; Humans; Male; Middle Aged; Norfloxacin; Prostate; Prostatitis | 1986 |
Norfloxacin in prostatitis: correlation between HPLC tissue concentrations and clinical results.
Topics: Administration, Oral; Adult; Chromatography, High Pressure Liquid; Humans; Kinetics; Male; Middle Ag | 1985 |